Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...

With drugs like Novo Nordisk's Wegovy becoming household names over the last couple of years, it's no surprise that there are ...

Dr. Darien Sutton joins GMA to discuss whether weight loss drugs are having an impact on dropping obesity rates.

Over 18 months, people taking Zepbound lost more weight on average than those on Wegovy, according to the first head-to-head ...

A new study reveals a decline in obesity rates in the US for the first time in over a decade. Analysis of 16.7 million adults ...

If the state’s rates continue as projected, 54% of males and 67% of females ages 15 to 25 will be overweight or obese by 2050 ...

Many sleep experts recommend exercising in the morning, but some people can exercise at night without harming their sleep.

A panel skewered "The View" co-host Whoopi Goldberg after she bristled at RFK, Jr. for suggesting Americans should try to lead healthy lives before resorting to weight-loss drugs.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 491.86% and ...

Discover the latest research findings on obesity in the United States, including a slight decrease in prevalence among adults in 2023. Learn more here.

Patients who have heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF) and high body mass index ...

For the first time in a decade, obesity in the U.S. is declining — and a new study suggests it’s because of wildly popular medications such as Ozempic.